---
title: "WDM plans to grant 12 million stock options with an exercise price of 15.18 yuan per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/232745634.md"
description: "WDM announced the 2025 stock option incentive plan, intending to grant 12 million stock options, of which 10.8 million will be granted initially, with 1.2 million reserved. The exercise price is set at 15.18 yuan per share. The initial grant will target 87 individuals, and the incentive plan will be valid for a maximum of 60 months"
datetime: "2025-03-21T12:40:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/232745634.md)
  - [en](https://longbridge.com/en/news/232745634.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/232745634.md)
generator: "portal-rs"
---

# WDM plans to grant 12 million stock options with an exercise price of 15.18 yuan per share

According to the Zhitong Finance APP, WanDong Medical (600055.SH) has disclosed the draft of its 2025 stock option incentive plan, which proposes to grant a total of 12 million stock options to the incentive recipients (with an initial grant of 10.8 million and a reserve of 1.2 million). The exercise price is set at 15.18 yuan per option. A total of 87 individuals will receive the initial grant.

This incentive plan is valid from the date of stock option grant until all stock options granted to the incentive recipients are exercised or canceled, with a maximum duration of 60 months

### Related Stocks

- [600055.CN](https://longbridge.com/en/quote/600055.CN.md)

## Related News & Research

- [BABA-W  Grants 1.93M Award Shares](https://longbridge.com/en/news/296803955.md)
- [Dividend 15 Split Corp. PFD SHARES declares CAD 0.0583 dividend](https://longbridge.com/en/news/296375789.md)
- [Dividend 15 Split Corp. II declares monthly distributions of $0.1 for Class A shares, $0.06 for preferred shares](https://longbridge.com/en/news/296360313.md)
- [07:15 ETBrennan Investment Group Expands into Phoenix with Appointment of Matt Field as Senior Vice President](https://longbridge.com/en/news/296778890.md)
- [Ashtead Technology Expects FY2026 Adjusted EBITDA To Be Around 15% Below Market Consensus](https://longbridge.com/en/news/296444281.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**